MISSO, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 862
EU - Europa 819
AS - Asia 219
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1907
Nazione #
US - Stati Uniti d'America 858
IT - Italia 203
UA - Ucraina 182
GB - Regno Unito 181
CN - Cina 80
DE - Germania 75
VN - Vietnam 72
FI - Finlandia 54
GR - Grecia 53
TR - Turchia 41
FR - Francia 32
SE - Svezia 27
PK - Pakistan 10
BE - Belgio 6
CA - Canada 4
IN - India 4
JP - Giappone 4
KR - Corea 4
IR - Iran 3
SC - Seychelles 3
NL - Olanda 2
RU - Federazione Russa 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
EU - Europa 1
ID - Indonesia 1
KE - Kenya 1
SI - Slovenia 1
Totale 1907
Città #
Jacksonville 300
Ann Arbor 81
Dong Ket 72
Princeton 69
Medford 61
Roxbury 53
Beijing 42
Caserta 42
Woodbridge 36
Chandler 35
Wilmington 29
Des Moines 24
San Mateo 20
Napoli 19
Mountain View 15
Cambridge 11
Falls Church 8
Milan 8
Cava Dei Tirreni 7
Brussels 6
Düsseldorf 6
Helsinki 6
Zhengzhou 6
Auburn Hills 5
Nanjing 5
Avellino 4
Gunzenhausen 4
Houston 4
Bascape 3
Castellammare Di Stabia 3
Jinan 3
Norwalk 3
Nottingham 3
Saviano 3
Tianjin 3
Washington 3
Aversa 2
Capri 2
Castel Volturno 2
Forino 2
Haikou 2
Hebei 2
Latina 2
London 2
Los Angeles 2
Naples 2
Prata 2
Redwood City 2
Shanghai 2
Shenyang 2
Vellore 2
Caiazzo 1
Campodarsego 1
Capua 1
Catania 1
Centro 1
Changsha 1
Clifton Park 1
Elora 1
Fairfield 1
Ferrara 1
Florence 1
Frattamaggiore 1
Giugliano In Campania 1
Grafing 1
Gragnano 1
Groningen 1
Guangzhou 1
Hangzhou 1
Hanover 1
Hyderabad 1
Jiaxing 1
Jinhua 1
Kish 1
Kunming 1
Lahore 1
Lanzhou 1
Leawood 1
Limatola 1
Ljubljana 1
Montespertoli 1
Muenster 1
Nanchang 1
Nürnberg 1
Orange 1
Palermo 1
Prato 1
Rome 1
Rostock 1
San Leucio 1
Santa Maria Capua Vetere 1
Scafati 1
Seoul 1
Sydney 1
Taizhou 1
Telese 1
Venice 1
Vienna 1
Totale 1079
Nome #
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 63
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 56
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 55
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 51
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 47
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 47
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 47
Measurement of autophagy by flow cytometry 44
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 44
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 43
Mitochondria as playmakers of apoptosis, autophagy and senescence 43
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 42
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 39
Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. 38
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 38
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 38
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 36
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients. 36
Gene interference strategies as a new tool for the treatment of prostate cancer 36
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 36
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 35
Tumour-specific uptake of anti-cancer drugs: the future is here. 35
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. 35
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. 33
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 33
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 33
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis). 32
Mir-34: a new weapon against cancer? 32
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 32
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 32
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 31
Optimal Management of Prostate Cancer Based on its Natural Clinical History 31
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. 30
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. 29
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. 29
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 29
Lipid Nanoparticles to Deliver miRNA in Cancer 29
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. 28
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports 28
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 28
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians 28
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 27
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 27
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 27
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 26
Bisphosphonates and cancer: what opportunities from nanotechnology? 25
Emerging pathways as individualized therapeutic target of multiple myeloma. 25
Hepatocarcinoma: genetic and epigenetic features 25
Non-coding RNAs as a new dawn in tumor diagnosis 24
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 24
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion 24
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 24
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research 23
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma 23
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response 21
MICRO-RNAs as biological markers for prevention and diagnosis of oral carcinomas 21
Prognostic patterns for predicting lymph node metastasis in patients with squamous cell carcinoma of the larynx 21
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 21
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. 20
Role of perineural invasion as a prognostic factor in laryngeal cancer 20
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 19
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 18
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 17
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems 12
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 12
Poorly differentiated neuroendocrine larynx carcinoma: Clinical features and mirnas signature—a new goal for early diagnosis and therapy? 11
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(Iii) complex with superior anticancer bioactivity 8
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 8
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 7
Totale 2121
Categoria #
all - tutte 3649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3649

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018192 00057 2511 1930 11141510
2018/2019182 63811 6413 187 1412116
2019/2020439 9660813 6311 7722 26212913
2020/2021525 3965727 6013 6447 29426180
2021/2022444 231217 14711 614 182543137
2022/2023165 12519183 00 00 0000
Totale 2121